Table 1 Standardized incidence rates (SIR) analysis with 95 % confidence intervals (CI) for cancer (overall and the six most prevalent sites) in the cohort compared to the general male population in Oslo and Akershus
From: Cholesterol and prostate cancer risk: a long-term prospective cohort study
Observed | Expected | SIR (95 % CI) | |
|---|---|---|---|
Cancer, overall | 758 | 798.3 | 0.95 (0.88–1.02) |
Colon | 87 | 81.9 | 1.06 (0.86–1.31) |
Rectum | 44 | 47.4 | 0.93 (0.69–1.25) |
Lung | 109 | 126.0 | 0.86 (0.72–1.04) |
Prostate | 213 | 201.7 | 1.06 (0.92–1.21) |
Bladder and kidney | 104 | 100.7 | 1.03 (0.85–1.25) |
Melanoma | 94 | 83.7 | 1.12 (0.92–1.37) |